I am happy to back up. But do note, AVZ does not back up all its purported facts:
example : in the 2018 October scoping study it quoted Premier Africa Metals scoping study on modelling Spodumene concentrate prices.
Not only did AVZ footnote the source as from FT, FT did not publish SC prices. And AVZ could have gone direct to the primary source: Premier Africa metals PAM website but it chose Financial Times, a secondary source and ‘misquoted’ so. And on top of that when you go to the premier Africa metals site, for Zulu scoping study, AVZ has ‘misquoted’ PAM as SC5 whereas it is SC6. AVZ did this so it could argue its SC6 will get extra dollars per % 0.1 of SC, which means it could beef up a key metric in its scoping study. At the time many argued about the pricing as reasonable or not. My point is honest practice.
Dont worry, Nigel was told by phone about the fraudulent citation, by yes u know who. The only reason it may have not been amended is one huge embarrassment and that it was pricing matching purported Chinese reports on pricing.
if you want the paper trail just ask. But all these facts are in public domain AVZ website and PAM’s and FT’s by absence.
any thing else you want substantiate just ask. Remember AVZ does not have to go to court to substantiate its statements before releasing them on ASX - when it was listed…
KoBold Makes Offer for Congo Lithium as Country Courts US, page-2595
Add to My Watchlist
What is My Watchlist?